Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites

Progressive elevations of fibroblastic growth factor 23 [FGF23] in chronic kidney disease may reduce serum 25-hydroxyvitamin D [25(OH)] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, via stimulation of 24-hydroxylase (Cyp24A1) mediated catabolism of these vitamin D metabolites. To test this possib...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dai, Bing, David, Valentin, Alshayeb, Hala M., Showkat, A., Gyamlani, G, Horst, Ronald L., Wall, Barry M., Quarles, L. Darryl
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461248/
https://ncbi.nlm.nih.gov/pubmed/22739976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2012.222
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky